Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease & Diabetes
Glycemic status in heart disease patients may help detect type 2 diabetes
September 27th, 2004
An analysis of more than 39,000 potential participants in the global NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial showed that an automatic assessment of glycemic status may improve unrecognized detection of type 2 diabetes and impaired glucose tolerance in people with heart disease or with risk factors for it. Researchers found of those screened for the trial, one in four had undiagnosed type 2 diabetes, and a further 25% to 30% had previously unrecognized impaired glucose tolerance (IGT, also known as a pre-diabetes condition which frequently progresses to clinical diabetes). "Physicians have long...
Source: Diabetes Week (2004-09-27)
|
